Table of Contents
Scope and Themes
-
- What you need to know
- Definition
- Abbreviations and terms
- Abbreviations
- Terms
Executive Summary
-
- Snapshot of the medicated skincare market
- Driving sales in the medicated skincare market
- Prevalence of skin conditions drives sales
- Treatment specialization increases per person purchases
- Private label keeps pace with name brands, keeping price points low
- Natural ingredients important in the medicated skincare market
- Male specific products contribute to sales growth
- Steady sales growth of market result of various segment ups and downs
- Drug stores hold position as top retailer; mass gains preference
- Skin irritation commonly self-treated
- First aid/antibiotics usage higher among women and whites, treatment similar across demographics
- Facial cleansing/medicated product usage statistics
- Natural ingredients, multiple benefits and scent important…to women
- Teens play an important role in the medicated skincare market
- Demographic groups and product trends driving future market growth
Market Drivers
-
- Skin problem incidence and treatment
- Cold sores
- Acne
-
- Figure 1: U.S. population by age, 2002-12
- Warts
- Lice
- Other skin irritations
- Athlete’s foot/nail fungus
- Treatment specialization
- Private label keeps pace with innovation
- Interest in natural products finds it way to medicated skincare
- First aid, topical antibiotics
- Acne treatments
- Lip balm, cold sore medications
- Foot care/ athlete’s foot treatments
- Lice treatments
- Wart removers
- Men’s-specific products bring sales to the market
-
- Figure 2: Male population by age, 2002-12
- Ethnic trends, population and spending power grows sales
-
- Figure 3: Use of facial cleansing and medicated products, by race/ethnicity, January-October 2006
-
- Figure 4: Population by race and Hispanic origin, 2002-12
Market Size and Trends
-
- Market size
-
- Figure 5: FDM sales of medicated skincare, at current and constant prices, 2001-06
- Wal-Mart estimate
- Market trends
-
- Figure 6: Number of new product launches by medicated skincare segment, 2001-06
- Natural ingredients/positioning
- Benefit bundling
- Convenient delivery/packaging
Market Segmentation
-
- Overview
-
- Figure 7: U.S. sales of medicated skincare products, by segment, 2004 and 2006
- First aid, topical antibiotics
-
- Figure 8: Sales of first aid, topical antibiotics, at current and constant prices, 2001-06
- Lip balm, cold sore medications
-
- Figure 9: Sales of lip balm, cold sore medications, at current and constant prices, 2001-06
- Acne treatments
-
- Figure 10: Sales of acne treatments, at current and constant prices, 2001-06
- Anti-itch treatments
-
- Figure 11: Sales of anti-itch treatments, at current and constant prices, 2001-06
- Foot care/athlete’s foot treatments
-
- Figure 12: Sales of foot care/athlete’s foot treatments, at current and constant prices, 2001-06
- Wart removers
-
- Figure 13: Sales of wart removers, at current and constant prices, 2001-06
- Lice treatments
-
- Figure 14: Sales of lice treatments, at current and constant prices, 2001-06
Supply Structure
-
- Company and brand sales
- FDM sales by manufacturer
-
- Figure 15: Manufacturer sales of medicated skincare in the U.S., 2004 and 2006
- First aid ointments/topical antiseptics
-
- Figure 16: Manufacturer brand sales of first aid ointments/antiseptics in the U.S., 2004 and 2006
- Lip balm/cold sore medication
-
- Figure 17: Manufacturer brand sales of lip balm/cold sore medication in the U.S., 2004 and 2006
- Acne treatments
-
- Figure 18: Manufacturer brand sales of acne treatments in the U.S., 2004 and 2006
- Anti-Itch treatments
-
- Figure 19: Manufacturer brand sales of anti-itch treatments in the U.S., 2004 and 2006
- Foot care/athlete’s foot medications
-
- Figure 20: Manufacturer brand sales foot care/athlete’s foot medications in the U.S., 2004 and 2006
- Wart removers
-
- Figure 21: Manufacturer brand sales of wart removers in the U.S., 2004 and 2006
- Lice treatments
-
- Figure 22: Manufacturer brand sales of lice treatments in the U.S., 2004 and 2006
Advertising and Promotion
-
- Pfizer
-
- Figure 23: Television spot: Neosporin antibiotic ointment—scientific positioning; improved efficacy
- Johnson & Johnson
-
- Figure 24: Television spot: Cortaid Advanced anti-itch treatment—scientific positioning; response to consumer feedback; improved efficacy
- Schering-Plough
-
- Figure 25: Television spot: Dr. Scholl’s Dual Action Freeze Away wart remover—physician strength; improved efficacy
- Combe, Inc.
-
- Figure 26: Television spot: Lanacane anti-itch treatment—benefit bundling; improved efficacy
-
- Figure 27: Television spot: Scalpicin scalp itch treatment—specific condition
- Merz Pharmaceuticals
-
- Figure 28: Television spot: Mederma scar treatment—doctor recommended; cosmetic properties
- Chattem Inc.
-
- Figure 29: Television spot: Gold Bond anti-itch treatment—multi-condition benefits
- Stiefel Labs
-
- Figure 30: Television spot: Sarna anti-itch treatment—active ingredients
- Quaker House Products
-
- Figure 31: Television spot: Blue Star anti-itch treatment—multi-condition benefits
- AVVAA World Health Care Products
-
- Figure 32: Television spot: Neuroskin itch treatment—benefit bundling
Retail Distribution
-
- Introduction
-
- Figure 33: Retail sales of medicated skincare, by channel, 2004 and 2006
- Drug stores
-
- Figure 34: U.S. drug store sales of medicated skincare products, at current and constant prices, 2001-06
- Mass merchandisers
-
- Figure 35: U.S. mass merchandiser sales of medicated skincare products, at current and constant prices,
- Supermarkets
-
- Figure 36: U.S. supermarket sales of medicated skincare products, at current and constant prices, 2001-06
The Consumer: Skin Conditions and Irritations
-
- Introduction
- Summary
- Skin irritations
- Severity of irritations
- Preferred treatment
- Nail fungus, athlete’s foot and eczema/psoriasis
- First aid/antibiotics
- Treatment of minor cuts and scrapes
- Skin irritation incidence
-
- Figure 37: Incidence of specific skin conditions, by gender, February 2007
-
- Figure 38: Incidence of specific skin conditions, by age, February 2007
-
- Figure 39: Incidence of specific skin conditions, past three months and past 12 months, February 2007
-
- Figure 40: Incidence of specific skin conditions, past 12 months, by race/ethnicity, February 2007
- Condition severity
-
- Figure 41: Incidence of specific skin conditions, February 2007
- Preferred treatment methods for specific conditions
-
- Figure 42: Preferred treatments for specific skin conditions, February 2007
- Condition severity and use of prescription vs. OTC remedies
-
- Figure 43: Severity of nail fungus/athlete’s foot/eczema/psoriasis and use of Rx or OTC remedy, January-October 2006
- Nail fungus
-
- Figure 44: Use of Rx or OTC remedy by severity of nail fungus, January-October 2006
- Athlete’s foot
-
- Figure 45: Use of Rx or OTC remedy by severity of athlete’s foot, January-October 2006
- Eczema/psoriasis
-
- Figure 46: Use of Rx or OTC remedy by severity of nail fungus, January-October 2006
- Use of first aid/antibiotic remedies
-
- Figure 47: Use of first aid/antibiotic remedies, by gender, age and race/ethnicity, January-October 2006
- Types and brands of first aid/antibiotic remedies
-
- Figure 48: Types and brands of first aid/antibiotic remedies, January-October 2006
- Treatment methods for minor cuts or scrapes
-
- Figure 49: Preferred treatments for minor cuts or scrapes, February 2007
The Consumer: Medicated Facial Skincare Products
-
- Summary
- Facial cleansing and medicated product usage
- Types used
- Facial cleansing and medicated skincare brand usage
- Reasons for using
- Use of facial cleansing and medicated skincare products
-
- Figure 50: Use of facial cleansing and medicated skincare products, by gender, age and race/ethnicity, January -October 2006
- Usage frequency of facial cleansing and medicated skincare products
-
- Figure 51: Usage frequency of facial cleansing products, January-October 2006
- Types and brands of facial cleansing and medicated skincare products
-
- Figure 52: Types and brands of facial cleansing and medicated skincare products, by gender, January-October 2006
-
- Figure 53: Types of facial cleansing and medicated skincare products, by age, January-October 2006
- Reasons for using facial cleansing and medicated skincare products
-
- Figure 54: Reasons for using facial cleansing and medicated skincare products, by gender,
- Usage rate for preferred facial skincare methods
-
- Figure 55: Usage rate for preferred facial skincare methods, by gender, February 2007
The Consumer: Attitudes and Opinions
-
- Summary
- Opinions of OTC remedies
- Incidence of dermatologist consultation
- Attitudes towards OTC medicated skincare remedies
-
- Figure 56: Attitudes towards OTC medicated skincare products, January-October 2006
- Attitudes towards medicated skincare products
-
- Figure 57: Attitudes towards medicated skincare products, by gender, February 2007
The Teen Consumer and Medicated Skincare
-
- Summary
- Incidence and severity of skin irritations/conditions among teens
- Teens’ facial cleansing and medicated skincare product usage
- Condition incidence among teens
-
- Figure 58: Incidence of specific skin conditions among teens, by gender, February 2007
- Condition severity
-
- Figure 59: Incidence of specific skin conditions, February 2007
- Teen use of facial cleansing and medicated skincare products
-
- Figure 60: Teen use of facial cleansing and medicated skincare products, by gender, January-October 2006
- Types and brands of facial cleansing and medicated skincare products used among teens
-
- Figure 61: Types and brands of facial cleansing and medicated skincare products among teens, by gender, January - October 2006
- Reasons for teen use of facial cleansing and medicated skincare products
-
- Figure 62: Reasons for teen use of facial cleansing and medicated skincare products, by gender, January-October 2006
- Usage frequency of facial cleansing products among teens
-
- Figure 63: Teen usage frequency of facial cleansing products, January-October 2006
Future and Forecast
-
- Future trends
- Ethnicities continue penetration
- Further specialization
- Natural ingredients surge
- Beyond metrosexual
- Market forecast
- Medicated skincare
-
- Figure 64: Forecast of total U.S. sales of medicated skincare, at current and constant prices, 2006-11
- First aid and topical antibiotics
-
- Figure 65: Forecast of U.S. sales of first aid and topical antibiotics, at current and constant prices, 2006-11
- Lip balm and cold sore medications
-
- Figure 66: Forecast of U.S. sales of lip balm and cold sore medications, at current and constant prices, 2006-11
- Acne treatments
-
- Figure 67: Forecast of U.S. sales of acne treatments, at current and constant prices, 2006-11
- Anti-itch treatments
-
- Figure 68: Forecast of U.S. sales of anti-itch treatments, at current and constant prices, 2006-11
- Foot care and athlete’s foot treatments
-
- Figure 69: Forecast of U.S. sales of foot care and athlete’s foot treatments, at current and constant prices, 2006-11
- Forecast factors
Appendix: Trade Associations
Back to top